Covered recipient · General Payments record
BILLY E GREENING
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2021
$764.66
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $370.15 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $227.09 | 12 |
| Abbott Laboratories | $40.22 | 2 |
| Lilly USA, LLC | $39.17 | 2 |
| ABBVIE INC. | $36.57 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.05 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833654893 | CMS |
| Abbott Laboratories | $19.17 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833654891 | CMS |
| AbbVie Inc. | $21.33 | 03/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794667581 | CMS |
| AbbVie Inc. | $15.24 | 06/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794667585 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.10 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763691416 | CMS |
| Lilly USA, LLC | $26.22 | 01/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818980291 | CMS |
| Lilly USA, LLC | $12.95 | 06/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818984711 | CMS |
| Novo Nordisk Inc | $2.91 | 01/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811503241 | CMS |
| Novo Nordisk Inc | $16.69 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811324533 | CMS |
| Novo Nordisk Inc | $17.83 | 02/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811112607 | CMS |
| Novo Nordisk Inc | $5.98 | 03/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811324537 | CMS |
| Novo Nordisk Inc | $18.40 | 06/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811503247 | CMS |
| Novo Nordisk Inc | $103.33 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829450651 | CMS |
| Novo Nordisk Inc | $11.77 | 06/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811324543 | CMS |
| Novo Nordisk Inc | $17.02 | 07/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811112937 | CMS |
| Novo Nordisk Inc | $5.59 | 07/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811112943 | CMS |
| Novo Nordisk Inc | $10.25 | 08/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811112613 | CMS |
| Novo Nordisk Inc | $4.97 | 08/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811760785 | CMS |
| Novo Nordisk Inc | $12.35 | 09/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810853293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.